Development · 10 Oct 2026

Zomato founder Deepinder Goyal claimed that Eternal directly supports the livelihoods of well over 1% of India's population and hopes to raise that figure to 5% by 2030.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

moneycontrol.com10 Oct 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Eternal

₹323.45

▲ +1.38%

Close (EOD), as of 9 Oct 2026 · source

Eternal: results, dividends, orders, the full cited record →

More on Eternal

Blinkit, a subsidiary of Eternal, has continued to deliver strong growth, supported by dark-store expansion and increasing category penetration.

8 Oct 2026 · 1 publisher

Benchmark equity indices closed lower on Wednesday, with the Nifty falling nearly 0.5 per cent, dragged by heavyweight stocks including Apollo Hospitals, Max Healthcare, Eternal and pharma companies.

30 Sep 2026 · 1 publisher

Eternal founder Deepinder Goyal introduced four researchers credited with developing Temple's Brain Flow technology: Dr. Divya Gulati from the Indian Institute of Science (IISc), Dr. Sanchit Gupta from IISc, Dr. Yukti Chopra from SISSA in Trieste, Italy, and Nitish Kumar from IIT Bombay.

28 Sep 2026 · 1 publisher

Eternal, formerly Zomato, has seen total income surge to ₹55,760 crore in FY26, translating into a four-year CAGR of over 80 per cent.

26 Sep 2026 · 1 publisher

Eternal's share price hit an 11-month high of ₹339.80, gaining 1.4% on the BSE in Tuesday's intra-day deals amid heavy volume.

22 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.